Beat Flühmann

871 total citations
28 papers, 562 citations indexed

About

Beat Flühmann is a scholar working on Hematology, Economics and Econometrics and Genetics. According to data from OpenAlex, Beat Flühmann has authored 28 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Economics and Econometrics and 7 papers in Genetics. Recurrent topics in Beat Flühmann's work include Iron Metabolism and Disorders (13 papers), Pharmaceutical Economics and Policy (8 papers) and Nanoparticle-Based Drug Delivery (7 papers). Beat Flühmann is often cited by papers focused on Iron Metabolism and Disorders (13 papers), Pharmaceutical Economics and Policy (8 papers) and Nanoparticle-Based Drug Delivery (7 papers). Beat Flühmann collaborates with scholars based in Switzerland, United States and Netherlands. Beat Flühmann's co-authors include Stefan Mühlebach, Gerrit Borchard, Vinod P. Shah, Daan J.A. Crommelin, Jon S. B. de Vlieger, Vera Weinstein, Ioanna Ntai, Scott E. McNeil, Steven Simoens and Felix Funk and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Beat Flühmann

25 papers receiving 539 citations

Peers

Countries citing papers authored by Beat Flühmann

Since Specialization

Citations

This map shows the geographic impact of Beat Flühmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beat Flühmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beat Flühmann more than expected).

Fields of papers citing papers by Beat Flühmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beat Flühmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beat Flühmann. The network helps show where Beat Flühmann may publish in the future.

Co-authorship network of co-authors of Beat Flühmann

This figure shows the co-authorship network connecting the top 25 collaborators of Beat Flühmann. A scholar is included among the top collaborators of Beat Flühmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beat Flühmann. Beat Flühmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Challenging Traditional ADME Assumptions for Physiologically Based Pharmacokinetic Models for Intravenous Administration of Iron–Carbohydrate Nanomedicines: Potential Utility of Gold Nanoparticle Models as a Roadmap 2025 ·Clinical Pharmacokinetics ·Amy Barton Pai, Zhoumeng Lin, Heather H. Gustafson, Beat Flühmann, (unknown), Vanesa Ayala‐Nunez, Stephan Schmidt	0
2	Tracking Intracellular Labile Iron with a Genetically Encoded Fluorescent Reporter System Based on Protein Stability 2025 ·ACS Sensors ·(unknown), (unknown), Benjamin Gottschalk, (unknown), (unknown), Amy Barton Pai, (unknown), Beat Flühmann, Emrah Eroğlu, Wolfgang F. Graier, Roland Malli	0
3	Understanding the kinetics of macrophage uptake and the metabolic fate of iron-carbohydrate complexes used for iron deficiency anemia treatment 2025 ·Journal of Controlled Release ·(unknown), Vera M. Kissling, (unknown), (unknown), (unknown), (unknown), (unknown), Alexander Gogos, (unknown), (unknown), Rafael Riudavets Puig, (unknown), (unknown), Beat Flühmann, Peter Wick, Vanesa Ayala‐Nunez	0
4	Nano-scale characterization of iron-carbohydrate complexes by cryogenic scanning transmission electron microscopy: Building the bridge to biorelevant characterization 2024 ·Heliyon ·(unknown), (unknown), (unknown), Alla S. Sologubenko, Andrzej J. Rzepiela, Stephan Handschin, (unknown), Beat Flühmann, (unknown)	4
5	Iron-carbohydrate complexes treating iron anaemia: Understanding the nano-structure and interactions with proteins through orthogonal characterisation 2024 ·Journal of Controlled Release ·(unknown), Jonathan Avaro, Marianne Liebi, (unknown), Joachim Kohlbrecher, Alla S. Sologubenko, Stephan Handschin, Andrzej J. Rzepiela, Christian Appel, (unknown), Clément Blanchet, (unknown), (unknown), (unknown), Beat Flühmann, Bruno F. B. Silva, A. Neels, Peter Wick	8
6	Uncovering the dynamics of cellular responses induced by iron-carbohydrate complexes in human macrophages using quantitative proteomics and phosphoproteomics 2023 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), (unknown), Beat Flühmann, (unknown), Marija Buljan, Vanesa Ayala‐Nunez, Peter Wick	2
7	Critical nanomaterial attributes of iron-carbohydrate nanoparticles: Leveraging orthogonal methods to resolve the 3-dimensional structure 2023 ·European Journal of Pharmaceutical Sciences ·(unknown), Prachi Joshi, Andreas Kappler, Beat Flühmann, Amy Barton Pai, (unknown), Peter Wick, A. Neels	5
8	Putting square pegs in round holes: Why traditional pharmacokinetic principles cannot universally be applied to iron-carbohydrate complexes 2023 ·European Journal of Pharmaceutics and Biopharmaceutics ·Amy Barton Pai, (unknown), Beat Flühmann, Matthias G. Wacker	6
9	Need for Expansion of Pharmacy Education Globally for the Growing Field of Nanomedicine 2022 ·SHILAP Revista de lepidopterología ·(unknown), Gerrit Borchard, Matthias G. Wacker, Giorgia Pastorin, Imran Saleem, (unknown), Tamer Elbayoumi, Zhigang Zhao, Beat Flühmann	8
10	Criticality of Surface Characteristics of Intravenous Iron–Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics 2022 ·International Journal of Molecular Sciences ·Felix Funk, Beat Flühmann, (unknown)	24
11	Probing Subcellular Iron Availability with Genetically Encoded Nitric Oxide Biosensors 2022 ·Biosensors ·(unknown), Amy Barton Pai, Felix Funk, Beat Flühmann, Roland Malli, Wolfgang F. Graier, Emrah Eroğlu	4
12	Kupffer Cells and Blood Monocytes Orchestrate the Clearance of Iron–Carbohydrate Nanoparticles from Serum 2022 ·International Journal of Molecular Sciences ·Tasneem Arsiwala, Anne‐Cathrine S. Vogt, (unknown), Vania Manolova, Felix Funk, Beat Flühmann, Martin F. Bachmann	10
13	The Growing Field of Nanomedicine and Its Relevance to Pharmacy Curricula 2021 ·American Journal of Pharmaceutical Education ·Volkmar Weissig, Tamer Elbayoumi, Beat Flühmann, Amy J. Barton	17
14	A pragmatic regulatory approach for complex generics through the U.S. FDA 505(j) or 505(b)(2) approval pathways 2021 ·Annals of the New York Academy of Sciences ·Kevin Klein, Gerrit Borchard, Vinod P. Shah, Beat Flühmann, Scott E. McNeil, Jon S. B. de Vlieger	17
15	Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practice 2020 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), Gerrit Borchard, Heinrich Hofmann, (unknown), Beat Flühmann, Peter Wick	39
16	Differences Between Intravenous Iron Products: Focus on Treatment of Iron Deficiency in Chronic Heart Failure Patients 2019 ·ESC Heart Failure ·Alejandro Martín‐Malo, Gerrit Borchard, Beat Flühmann, Claudio Mori, Donald S. Silverberg, Ewa A. Jankowska	30
17	Nanomedicines: The magic bullets reaching their target? 2018 ·European Journal of Pharmaceutical Sciences ·Beat Flühmann, Ioanna Ntai, Gerrit Borchard, Steven Simoens, Stefan Mühlebach	68
18	Reflections on FDA Draft Guidance for Products Containing Nanomaterials: Is the Abbreviated New Drug Application (ANDA) a Suitable Pathway for Nanomedicines? 2018 ·The AAPS Journal ·Emily Marden, Ioanna Ntai, (unknown), Beat Flühmann	17
19	The similarity question for biologicals and non-biological complex drugs 2015 ·European Journal of Pharmaceutical Sciences ·Daan J.A. Crommelin, Vinod P. Shah, Imre Klebovich, Scott E. McNeil, Vera Weinstein, Beat Flühmann, Stefan Mühlebach, Jon S. B. de Vlieger	54
20	How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to Consider 2013 ·The AAPS Journal ·Huub Schellekens, Sven Stegemann, Vera Weinstein, Jon S. B. de Vlieger, Beat Flühmann, Stefan Mühlebach, Rogério Gaspar, Vinod P. Shah, Daan J.A. Crommelin	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact